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Biofunctionalized magnetic nanoparticles (BMNs) that provide unique advantages have been extensively used to
develop immunoassay methods. However, these developed magnetic methods have been used only for specific
immunoassays and not in studies of magnetic characteristics of materials. In this study, a common vibration sample
magnetometer (VSM) was used for the measurement of the hysteresis loop for different carcinoembryonic antigens
(CEA) concentrations (ΦCEA) based on the synthesized BMNs with anti-CEA coating. Additionally, magnetic parameters
such as magnetization (M), remanent magnetization (MR), saturation magnetization (MS), and normalized parameters
(ΔMR/MR and ΔMS/MS) were studied. Here, ΔMR and ΔMs were defined as the difference between any ΦCEA and zero
ΦCEA. The parameters M, ΔMR, and ΔMS increased with ΦCEA, and ΔMS showed the largest increase. Magnetic clusters
produced by the conjugation of the BMNs to CEAs showed a ΔMS greater than that of BMNs. Furthermore, the
relationship between ΔMS/MS and ΦCEA could be described by a characteristic logistic function, which was appropriate
for assaying the amount of CEAs. This analytic ΔMS/MS and the BMNs used in general magnetic immunoassays can be
used for upgrading the functions of the VSM and for studying the magnetic characteristics of materials.
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Biofunctionalized magnetic nanoparticlesBackground
Magnetic nanoparticles interest researchers because of
their potential applications in biomedicine, such as pro-
tein purification [1], magnetofection [2], tomographic
imaging [3], magnetic resonance imaging [4–6], mag-
netic immunoassays [7, 8], tumor diagnosis [9], and hy-
perthermia therapy [10]. In magnetic immunoassays,
magnetic nanoparticles are first biofunctionalized with
antibodies to obtain biofunctionalized magnetic nano-
particles (BMNs), which are then dissolved in solutions
to form magnetic reagents. To assay a biotarget, a mag-
netic reagent is mixed with a sample solution containing
the biotarget. The conjugation of BMNs with the biotarget
produces magnetic clusters because of molecular inter-
action (Fig. 1), and the magnetic properties of the reagent
changes. Biological samples, unconjugated BMNs, and
magnetic clusters of conjugated biotargets show a negli-
gible magnetic background individually and differ in their* Correspondence: jjchieh@ntnu.edu.tw
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provided the original work is properly creditedmagnetic characteristics. Hence, it is possible to develop
magnetic immunoassays on the basis of several parame-
ters and phenomena such as magnetic relaxation [11, 12],
remanent magnetization (MR) [13, 14], saturation mag-
netization (MS) [15], magnetic resonance [16, 17], and
alternating current (ac) susceptibility (χac) [8, 18–21].
In addition, because signal changes associated with the
magnetic characteristics of BMNs are always small, a
high-sensitivity high-critical-temperature superconducting
quantum interference device (SQUID) sensor is usually
used to enhance the signal-to-noise ratio and mu-metal
shielding is provided to reduce environmental noise. A
cryogenic biodetection system involving SQUIDs is diffi-
cult to construct.
Washing processes are sometimes required to separate
magnetic clusters from reagents for measuring magnetic
characteristics; however, they are time-consuming. There-
fore, developing a biodetection system featuring an alter-
native detection mechanism and high detection sensitivity
is crucial. A wash-free immunomagnetic reduction (IMR)
method based on ac magnetic susceptibility reduction
has been proposed [19], and various studies haveicle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Fig. 1 A scheme of CEAs, Fe3O4-anti-CEA, and Fe3O4-anti-CEA-CEA. Some Fe3O4-anti-CEAs become as magnetic cluster, Fe3O4-anti-CEA-CEA, after
binding to CEA antigen
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such as nucleic acids [20], biomarkers (for diagnosing
Alzheimer’s disease) [6], alpha-fetoprotein (for detecting
liver tumors) [7], and human C-reactive protein (for diag-
nosing inflammation) [15].
In this study, we proposed a magnetic immunoassay
method based on the BMNs used in magnetic immu-
noassay methods, like IMR; the proposed method does
not require a SQUID sensor or washing process. The
method involves the use of a vibration sample mag-
netometer (VSM) for measuring the hysteresis loop,
from which the major magnetic characteristics can be
inferred, and does not require a specific magnetic instru-
ment for magnetic immunoassays. The magnetic para-
meters of the hysteresis loop were studied to determine
the analytic method of magnetic immunoassay. When
the method is applied to magnetic immunoassays, the
magnetic parameters of the analytics are determined
from the hysteresis loop.
Methods
Figure 1 shows a schematic of the clustering process in-
volving BMNs and dextran-coated Fe3O4 nanoparticles.
The procedures used for synthesizing BMNs consisting
of anticarcinoembryonic antigens (anti-CEAs) coated
on dextran-coated Fe3O4 nanoparticles (MF-DEX-0060,
MagQu Corp., Taiwan) were similar to those used in a
previous study for synthesizing dextran-coated Fe3O4
nanoparticles coated with anti-goat C-reactive protein
[22]. Dextran-coated Fe3O4 nanoparticles was oxidized
using NaIO4 to create aldehyde groups (−CHO), and
dextran reacted with the antibodies of anti-CEAs (10C-
CR2014M5, Fitzgerald, MA, USA) through −CH = N- to
covalently conjugate the antibodies of anti-CEAs. Aftermagnetic separation, the unbound antibodies were sepa-
rated from conjugated BMNs consisting of dextran-coated
Fe3O4 nanoparticles coated with anticarcinoembryonic
antigens (Fe3O4-anti-CEAs). Subsequently, a reagent
was synthesized by dissolving the BMNs in phosphate-
buffered saline. The biotargets were carcinoembryonic
antigens (CEAs; 30-AC30, Fitzgerald, MA, USA). These
antigens are typically used as a tumor marker for colorec-
tal cancers, which are caused by uncontrolled cell growth
in the colon or rectum [23] and are the second leading
cause of cancer death in adults worldwide [24].
The mean value of the hydrodynamic diameter of the
BMNs was 40.8 nm, as detected through dynamic laser
scattering (Nanotrac 150, Microtrac, PA, USA). The con-
jugation capability of BMNs was verified by tissue staining.
The colon tumors induced on the backs of mice were
sampled to form paraffin-embedded sections. Figure 2a
shows the process of staining the colon tumor tissue with
BMNs. First, the sections of the colon tumors were
immersed in the Fe3O4-anti-CEA reagent. Consequently,
a secondary antibody conjugated to a fluorescent indicator
(goat anti-rabbit IgG antibody, Millipore, USA) was added.
Here, the binding occurred because the fluorescent indica-
tor with an isothiocyanate reactive group was reactive
toward nucleophiles containing amine and sulfhydryl
groups on the protein [25]. Because of conjugation be-
tween the secondary antibodies and anti-CEA antibodies,
the fluorescent indicators were bound to the BMNs on
the tissue. Both the tissue and fluorescent indicators of
the BMNs were obtained through fluorescence micros-
copy (IX70, Olympus, Japan).
In assaying the CEAs, 40 μL of the Fe3O4-anti-CEA
reagent with a saturation magnetization of 0.07 emu/g
was mixed with 60 μL of a CEA solution with a CEA
Fig. 2 The stain of colon tumor tissue using the Fe3O4-anti-CEA reagent. a The stain process. b The fluorescence images with blue and green
colors, representative of the nucleus of a colon tumor cell and the fluorescence indicator on BMNs
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verify the formation of magnetic clusters during the
assay, the effective relaxation time τeff(t) was monitored.
This was because the presence of magnetic clusters
would increase τeff. Furthermore, χac(t) can be expressed
as follows [26, 27]:
χac tð Þ ¼ χac;0 1= 1 þ wτeff tð Þð Þ2
 1=2n o ð1Þ
Here, χac,0 is χac of the Fe3O4-anti-CEA reagent ini-
tially mixing with the CEA solution, and ω is the angular
frequency. Therefore, τeff can be obtained by substituting
Δχac, defined as χac,0 − χac, in Eq. (1). The test materials
were the Fe3O4-anti-CEA reagent and a CEA solution
with a ΦCEA of 10 ppm. The complete experiment
process first involved the measurement of the hysteresis
loop for only the Fe3O4-anti-CEA reagent by using the
VSM (Model Hystermag, MagQu Corp., Taiwan). Subse-
quently, χac for the mixture of the reagent and the CEA
solution was measured continuously during the entire
assay period by using an analyzer (χacPro-E101, MagQu
Corp., Taiwan). After the assay, the mixture was again
measured using the VSM.
For a ΦCEA of 10 ppm, the formation of magnetic clus-
ters in the assay of the CEAs was verified by measuring
χac along with the hysteresis loop during the assay
period. For all the other CEA concentrations (0, 0.01,
0.5, 1, 2.5, and 5 ppm), only the hysteresis loop was mea-
sured. Figure 3 shows a schematic of the measurement
of the hysteresis loop, which expresses the magnetizationM as a function of the applied field H. An electromagnet
that provided a maximum H of 1.0 T was used to deter-
mine M, MR, and MS. The sample was vibrated with a
frequency of approximately 30 Hz by using an oscillating
device. The magnetic signal was then detected using a
second-order gradient pickup coil. In addition to charac-
terizing the variation of ΔMR or ΔMS with ΦCEA, the rela-
tionship between ΔMR/MR or ΔMS/MS and ΦCEA, which
represented the merit function of the CEA amount, was
determined.
Results and Discussion
Figure 2b shows BMPs conjugated to the CEAs on the
tumor tissue. The blue and green colors represent the
nucleus of a colon tumor cell and the fluorescent indi-
cator, respectively. Here, the excitation/emission wave-
lengths of the observed green and blue colors were
495 nm/519 nm and 358 nm/461 nm, respectively.
Superposing these two images shows that the blue and
green spots are located in close proximity, indicating
that the BMPs were bound to colon tumor cells. The
proximity of the blue and green spots also confirms the
bioconjugation capability of the BMNs.
Figure 4a shows that χac was initially constant and that
it subsequently decreased with time and reached a
steady value. These stages corresponded to the precon-
jugation, conjugation, and postconjugation period, in
which the reference is to the conjugation between BMNs
and CEAs. In the immunomagnetic reduction (IMR)
assay [8, 18–21], the normalized parameter Δχac/χac (the
Fig. 3 The measurement scheme of the hysteresis loop using a VSM
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difference in χac between preconjugation χac,0 and post-
conjugation χac,f.
In addition to the χac measurement, typical hysteresis
loops of the Fe3O4-anti-CEA reagent before the assays
and the mixture of the same reagent and the CEAs after
assaying 10 ppm of CEAs are separately shown in Fig. 4b.
The parameter Ms for the reagent was equal to 0.07
emu/g at 0.15 T and near the saturation field, and Ms
was enhanced to 0.23 emu/g after the conjugation.
One part of the hysteresis loops for various ΦCEA
values is shown in Fig. 5a. For all ΦCEA values, M rapidly
increased with an increase in H from 0 to 1000 Oe, and
then gradually reached MS. Furthermore, for each H, M
(including MS) increased with ΦCEA. From the hysteresis
loops, both ΔMR at zero H and ΔMS at the maximum H,
defined as the difference between ΔMR and ΔMS be-
tween any ΦCEA and zero ΦCEA, also increased with
ΦCEA, as depicted in Fig. 5b, c. Each of the parameters
ΔMR and ΔMS increased to 0.009 and 0.17 emu/g for a
ΦCEA of 10 ppm.
To quantify the detected ΦCEA amount and to improve
the capability of distinguishing the small measured
values of M, the parameters ΔMR/MR and ΔMS/MS were
used. In addition to the increase in the variation of ΔMR
or ΔMS with ΦCEA, both ΔMR/MR and ΔMS/MS, repre-
sented as ΔMx/Mx, can be expressed by a characteristic lo-
gistic function ΦCEA, as shown in Fig. 6a, b [28, 29, 19]:
ΔMx=Mx ¼ A−Bð Þ= 1 þ ΦCEAð Þ= Φ0ð Þ½ γf g þ B ð2Þ
where A, B, and γ are dimensionless quantities, and Φ0
is the dimensional concentration. The parameters A, B,
γ, and Φ0 for the fitting curve were −0.2, 30.1, 0.5, and3222.7 ppm for x = R and 0.018, 83.3, 0.63, and 2874
ppm, respectively, for x = S.
A comparison of Fig. 4a, b, and c shows that χac de-
creased, and M, which was related to the dc magnetic sus-
ceptibility, increased after the assaying of the CEAs. The
opposite variations of the ac and dc magnetic susceptibi-
lities are attributed to the presence of magnetic clusters.
The verification performed in this study was for the in-
crease in τeff during conjugation, consistent with similar as-
says of C-reactive proteins [30]. Yang et al. [31] conducted
a study on temperature-dependent immunoreaction kinet-
ics of the BMN assay for biomarkers of colorectal cancer.
They observed a gradual increase in the mean diameter of
the magnetic nanoparticles from 41.53 to 45.13 nm after
the reagent and CEA solution were mixed. Their results
suggested the presence of magnetic clusters in the re-
agents. Here, the diameter of the magnetic cluster might
be considerably greater than 45.13 nm, as indicated in
Fig. 1. However, the magnetic clusters were confined to a
limited part of the entire Fe3O4-anti-CEA reagent. There-
fore, the observed increase in the mean diameter of the
mixture, consisting of the Fe3O4-anti-CEA reagent and
CEA solution, was small, even though individual magnetic
clusters showed a considerably larger increase.
Consequently, in Fig. 5, the higher the ΦCEA value, the
larger the ΔMR and ΔMS values. However, for small values
of ΔMR or ΔMS, it is difficult to determine the ΦCEA
amount because of the small difference between ΔMR and
ΔMS. The parameter ΔMR was scattered and negative
when ΦCEA was smaller than 0.1 ppm. The reason is that
the system noise intensity was greater than the intensity of
the signal for the low ΦCEA. Consequently, ΔMR/MR or
ΔMS/MS with larger values than ΔMR or ΔMS was used to
obtain a characteristic logistic function of ΦCEA. These
relationships were identified for assaying the amount of
Fig. 4 The magnetic measurements of χac and the hysteresis loop
for mixing 40 μL of the Fe3O4-anti-CEA reagent with 60 μL and 10 ppm
of a CEA solution. a The dynamic measurement of χac with time.
b Before and c after the measurement of χac, the measurement of
the hysteresis loop for only the Fe3O4-anti-CEA reagent as well as the
mixture of the same reagent and the CEAs
Fig. 5 The dependence of magnetic characteristics of on ΦCEA from
0.01 to 10 ppm. a One part of the hysteresis loop, the M variation
with H, under different ΦCEA. b ΔMS and c ΔMR as a function of ΦCEA
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Fig. 6 The dependence of normalized ΔMx/Mx on ΦCEA from 0.01 to
10 ppm. a ΔMR/MR and b ΔMS/MS as a function ΦCEA
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ΔMR/MR, it is suggested that ΔMS/MS can be used to
enhance the discrimination capability of ΦCEA in magnetic
immunoassays. In Fig. 5b, c, the detection limits of ΔMR/
MR and ΔMS/MS are 0.1 and 0.01 ppm, respectively. For
the mixture of the Fe3O4-anti-CEA reagent and CEAs,
if the mixing conditions such as the concentration or vol-
ume of each material can be optimized instead of the IMR
condition, the detection limit can be improved for a Φ
value of 0.005 ppm. This study performed a more detailed
investigation compared with a previous study [32]; the in-
vestigation included validating and comparing the analysis
of ΔMR/MR and ΔMS/MS, determining the immunoassay
capability of the Fe3O4-anti-CEA reagent by tissue stain-
ing, and verifying the presence of magnetic clusters
through an analysis of the effective relaxation time. More-
over, the biomarker studied here was also different from
that studied previously [32].The major clinical objectives of assaying CEAs are to
screen a colorectal cancer, evaluate the effect of colorectal
carcinoma treatment, identify recurrences after surgical
resection, and control the spread of cancer. Although a
variety of developed immunoassay methodologies exist,
such as enzyme-linked immunoassays [33, 34], Western
blot immunoassay [35, 36], fluorescence in situ hybri-
dization [37], and polymerase chain reactions [38], wash-
ing processes are always required to avoid inaccuracies in
the optical examination of sample interference colors.
This results in the immunoassays being time-consuming
and requiring large manpower. In this study, the magnetic
detection platform using BMNs neither depends on the
color of biological samples nor requires washing. The
established relationship between ΔMS/MS and ΦCEA fol-
lowed a characteristic logistic function and was used for
the determination of the CEA amount. The proposed
method can be applied to the analysis of other biotargets
once the relationship between ΔMS/MS and Φbiotargets is
established.
Conclusions
A detection mechanism was proposed to show thatMS for
BMNs consisting of Fe3O4-anti-CEAs increased after con-
jugation with CEAs. Hysteresis loops were measured and
analyzed to determine ΔMR/MR and ΔMS/MS. ΔMS/MS
showed higher sensitivity and greater discrimination cap-
ability than ΔMR/MR for assaying CEAs. Consequently,
the CEA amount could be determined using the relation-
ship between ΔMS/MS and ΦCEA, expressed by a universal
characteristic logistic function. This methodology has the
potential to be used for other targets; for this purpose,
magnetic reagents used in other magnetic immunoassays
can be used with the VSM, and no specific instrument
is required for applying the methodology to magnetic
immunoassays.
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